ACTICOR BIOTECH

ACTICOR

In the Statement, classes 1 and 42 have been corrected per the Restriction dated 12/10/20, and per the Fnote dated 1/26/2021.;Antibodies in the form of biological preparations for the prevention and treatment of arterial and venous thrombosis, restenosis, and thromboembolic diseases; pharmaceuticals for prevention and treatment of arterial and venous thrombosis, restenosis, and thromboembolic diseases; pharmaceutical preparations and substances prevention and treatment of arterial and venous thrombosis, restenosis, and thromboembolic diseases;Monoclonal antibodies for scientific use; [ reagents for scientific or medical research use; biochemicals for in vitro and in vivo scientific use and medical research use; ] biological preparations * of monoclonal antibodies * for use in industry and science [ ; proteins in raw material form for use in scientific research ];[ Medical and scientific laboratory services relating to the production of antibodies; ] biotechnological and pharmaceutical drug development services; pharmaceutical and biotechnological research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development in the pharmaceutical and biotechnology fields;